Solventum Corporation
SOLV
$81.01
-$1.41-1.71%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.01B | 2.00B | 2.10B | 2.16B | 2.07B |
| Total Other Revenue | 1.00M | -- | -- | -- | -- |
| Total Revenue | 2.01B | 2.00B | 2.10B | 2.16B | 2.07B |
| Cost of Revenue | 910.00M | 971.00M | 963.00M | 985.00M | 946.00M |
| Gross Profit | 1.10B | 1.03B | 1.13B | 1.18B | 1.12B |
| SG&A Expenses | 799.00M | 719.00M | 786.00M | 777.00M | 774.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.90B | 1.86B | 1.93B | 1.95B | 1.91B |
| Operating Income | 112.00M | 140.00M | 164.00M | 212.00M | 160.00M |
| Income Before Tax | 16.00M | 58.00M | 1.51B | 103.00M | 38.00M |
| Income Tax Expenses | 3.00M | -5.00M | 248.00M | 13.00M | -99.00M |
| Earnings from Continuing Operations | 13.00M | 63.00M | 1.27B | 90.00M | 137.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.00M | 63.00M | 1.27B | 90.00M | 137.00M |
| EBIT | 112.00M | 140.00M | 164.00M | 212.00M | 160.00M |
| EBITDA | 247.00M | 257.00M | 285.00M | 334.00M | 289.00M |
| EPS Basic | 0.07 | 0.36 | 7.26 | 0.52 | 0.79 |
| Normalized Basic EPS | 0.20 | 0.30 | 0.29 | 0.40 | 0.20 |
| EPS Diluted | 0.07 | 0.36 | 7.22 | 0.51 | 0.78 |
| Normalized Diluted EPS | 0.20 | 0.30 | 0.29 | 0.40 | 0.20 |
| Average Basic Shares Outstanding | 174.20M | 174.40M | 174.30M | 174.10M | 173.70M |
| Average Diluted Shares Outstanding | 175.50M | 175.70M | 175.40M | 175.20M | 174.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |